Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 225

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline

Open access
Ralston, Stuart H, Corral-Gudino, Luis, Cooper, Cyrus, Francis, Roger M, Fraser, William D, Gennari, Luigi, Guañabens, Núria, Javaid, M Kassim, Layfield, Robert, O'Neill, Terence W, Russell, R Graham G, Stone, Michael D, Simpson, Keith, Wilkinson, Diana, Wills, Ruth, Zillikens, M Carola, Tuck, Stephen P · 2019 · Journal of Bone and Mineral Research

Abstract

An evidence-based clinical guideline for the diagnosis and management of Paget's disease of bone (PDB) was developed using GRADE methodology, by a Guideline Development Group (GDG) led by the Paget's Association (UK). A systematic review of diagnostic tests and pharmacological and nonpharmacological treatment options was conducted that sought to address several key questions of clinical relevance. Twelve recommendations and five conditional recommendations were made, but there was insufficient evidence to address eight of the questions posed. The following recommendations were identified as the most important: 1) Radionuclide bone scans, in addition to targeted radiographs, are recommended as a means of fully and accurately defining the extent of metabolically active disease in patients with PDB. 2) Serum total alkaline phosphatase (ALP) is recommended as a first-line biochemical screening test in combination with liver function tests in screening for the presence of metabolically active PDB. 3) Bisphosphonates are recommended for the treatment of bone pain associated with PDB. Zoledronic acid is recommended as the bisphosphonate most likely to give a favorable pain response. 4) Treatment aimed at improving symptoms is recommended over a treat-to-target strategy aimed at normalizing total ALP in PDB. 5) Total hip or knee replacements are recommended for patients with PDB who develop osteoarthritis in whom medical treatment is inadequate. There is insufficient information to recommend one type of surgical approach over another. The guideline was endorsed by the European Calcified Tissues Society, the International Osteoporosis Foundation, the American Society of Bone and Mineral Research, the Bone Research Society (UK), and the British Geriatric Society. The GDG noted that there had been a lack of research on patient-focused clinical outcomes in PDB and identified several areas where further research was needed. © 2019 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jbmr.3657

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 125

  1. Davie, 1999, Paget's disease of bone: a review of 889 patients, Bone, 24, 11S, 10.1016/S8756-3282(99)00027-7 · DOI
  2. van Staa, 2002, Incidence and natural history of Paget's disease of bone in England and Wales, J Bone Miner Res, 17, 465, 10.1359/jbmr.2002.17.3.465 · DOI · Paper page
  3. Corral-Gudino, 2013, Epidemiology of Paget's disease of bone: a systematic review and meta-analysis of secular changes, Bone, 55, 347, 10.1016/j.bone.2013.04.024 · DOI
  4. Mays, 2010, Archaeological skeletons support a northwest European origin for Paget's disease of bone, J Bone Miner Res, 25, 1839, 10.1002/jbmr.64 · DOI
  5. Meunier, 1980, Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue, Arthritis Rheum, 23, 1095, 10.1002/art.1780231005 · DOI · Paper page
  6. Sofaer, 1983, A family study of Paget's disease of bone, J Epidemiol Community Health, 37, 226, 10.1136/jech.37.3.226 · DOI
  7. Siris, 1991, Familial aggregation of Paget's disease of bone, J Bone Miner Res, 6, 495, 10.1002/jbmr.5650060511 · DOI · Paper page
  8. Morales-Piga, 1995, Frequency and characteristics of familial aggregation of Paget's disease of bone, J Bone Miner Res, 10, 663, 10.1002/jbmr.5650100421 · DOI · Paper page
  9. Morissette, 2006, Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone, J Bone Miner Res, 38, 10.1359/jbmr.06s207 · DOI
  10. Hocking, 2000, Familial Paget's disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q, Bone, 26, 577, 10.1016/S8756-3282(00)00278-7 · DOI
  11. Moscat, 2009, p62 at the crossroads of autophagy, apoptosis, and cancer, Cell, 137, 1001, 10.1016/j.cell.2009.05.023 · DOI · Paper page
  12. Beyens, 2004, Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease, Calcif Tissue Int, 75, 144, 10.1007/s00223-004-0244-4 · DOI
  13. Jin, 2008, Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice, J Clin Invest, 118, 1858, 10.1172/JCI34257 · DOI · Paper page
  14. Hughes, 2000, Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis, Nat Genet, 24, 45, 10.1038/71667 · DOI · Paper page
  15. Whyte, 2002, Osteoprotegerin deficiency and juvenile Paget's disease, N Engl J Med, 347, 175, 10.1056/NEJMoa013096 · DOI · Paper page
  16. Divisato, 2016, ZNF687 mutations in severe Paget disease of bone associated with giant cell tumor, Am J Hum Genet, 98, 275, 10.1016/j.ajhg.2015.12.016 · DOI
  17. Kim, 2013, Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS, Nature, 495, 467, 10.1038/nature11922 · DOI · Paper page
  18. Albagha, 2011, Genome-wide association identifies three new susceptibility loci for Paget's disease of bone, Nat Genet, 43, 685, 10.1038/ng.845 · DOI · Paper page
  19. Bolland, 2007, Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations, J Bone Miner Res, 22, 411, 10.1359/jbmr.061204 · DOI
  20. Cundy, 2004, Paget's disease of bone in New Zealand: continued decline in disease severity, Calcif Tissue Int, 75, 358, 10.1007/s00223-004-0281-z · DOI
  21. Doyle, 2002, Paget's disease in New Zealand: evidence for declining prevalence, Bone, 31, 616, 10.1016/S8756-3282(02)00876-1 · DOI
  22. Poor, 2006, Epidemiology of Paget's disease in Europe: the prevalence is decreasing, J Bone Miner Res, 21, 1545, 10.1359/jbmr.060704 · DOI
  23. Corral-Gudino, 2013, Secular changes in Paget's disease: contrasting changes in the number of new referrals and in disease severity in two neighboring regions of Spain, Osteoporos Int, 24, 443, 10.1007/s00198-012-1954-5 · DOI
  24. Cooper, 1999, The epidemiology of Paget's disease in Britain: is the prevalence decreasing, J Bone Miner Res, 14, 192, 10.1359/jbmr.1999.14.2.192 · DOI · Paper page
  25. Britton, 2017, The changing presentation of Paget's disease of bone in Australia, a high prevalence region, Calcif Tissue Int, 101, 564, 10.1007/s00223-017-0312-1 · DOI
  26. Mangham, 2009, Sarcoma arising in Paget's disease of bone: declining incidence and increasing age at presentation, Bone, 44, 431, 10.1016/j.bone.2008.11.002 · DOI
  27. Siris, 1994, Epidemiological aspects of Paget's disease: family history and relationship to other medical conditions, Semin Arth Rheum, 23, 222, 10.1016/0049-0172(94)90037-X · DOI
  28. Lever, 2002, Paget's disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesis, Bone, 31, 434, 10.1016/S8756-3282(02)00833-5 · DOI
  29. Solomon, 1979, Billiard-player's fingers: an unusual case of Paget's disease of bone, Br Med J, 1, 931, 10.1136/bmj.1.6168.931 · DOI
  30. Hamdy, 1979, Trauma and Paget's disease of bone, Br Med J, 1, 1487, 10.1136/bmj.1.6176.1487-b · doi:10.1136/bmj.1.6176.1487-b
  31. Rebel, 1974, Ultrastructural characteristics of osteoclasts in Paget's disease, Rev Rhum Mal Osteoartic, 41, 767
  32. Mills, 1984, Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone, Clin Orthop Rel Res, 183, 303, 10.1097/00003086-198403000-00044 · DOI · Paper page
  33. O'Driscoll, 1985, Past pets and Paget's disease, Lancet, 2, 919, 10.1016/S0140-6736(85)90852-9 · DOI
  34. Teramachi, 2016, Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease, J Clin Invest, 126, 1012, 10.1172/JCI82012 · DOI
  35. Matthews, 2008, Failure to detect measles virus RNA in bone cells from patients with Paget's disease, J Clin Endocrinol Metab, 93, 1398, 10.1210/jc.2007-1978 · DOI
  36. Ralston, 1991, Failure to detect paramyxovirus sequences in Paget's disease of bone using the polymerase chain reaction, J Bone Miner Res, 6, 1243, 10.1002/jbmr.5650061115 · DOI
  37. Ralston, 2007, Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone, J Bone Miner Res, 22, 569, 10.1359/jbmr.070103 · DOI
  38. Helfrich, 2000, A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients, J Bone Miner Res, 15, 2315, 10.1359/jbmr.2000.15.12.2315 · DOI
  39. Gordon, 1992, Canine distemper transcripts sequenced from pagetic bone, Bone Miner, 19, 159, 10.1016/0169-6009(92)90923-2 · DOI
  40. Reddy, 1996, Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease, J Bone Miner Res, 11, 1602, 10.1002/jbmr.5650111103 · DOI
  41. Ooi, 2000, Absence of measles virus and canine distemper virus transcripts in long- term bone marrow cultures from patients with Paget's disease of bone, Bone, 27, 417, 10.1016/S8756-3282(00)00343-4 · DOI
  42. Birch, 1994, Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone, J Bone Miner Res, 9, 11, 10.1002/jbmr.5650090103 · DOI
  43. Visconti, 2017, Antibody response to paramyxoviruses in Paget's disease of bone, Calcif Tissue Int, 101, 141, 10.1007/s00223-017-0265-4 · DOI
  44. Helfrich, 2014, Genetics and aetiology of Pagetic disorders of Bone, Arch Biochem Biophys, 473, 172, 10.1016/j.abb.2008.02.045 · DOI
  45. Douglas, 1981, Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis, J Bone Joint Surg Br, 63B, 495, 10.1302/0301-620X.63B4.6457839 · DOI
  46. Tuck, 2017, Adult Paget's disease of bone: a review, Rheumatology (Oxford), 56, 2050, 10.1093/rheumatology/kew430 · DOI
  47. Tan, 2014, Clinical presentation of Paget's disease: evaluation of a contemporary cohort and systematic review, Calcif Tissue Int, 95, 385, 10.1007/s00223-014-9904-1 · DOI
  48. Reid, 1996, Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial, Am J Med, 101, 341, 10.1016/S0002-9343(96)00227-6 · DOI · Paper page
  49. Langston, 2010, Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone, J Bone Miner Res, 25, 20, 10.1359/jbmr.090709 · DOI · Paper page
  50. Ruggieri, 2010, The role of surgery and adjuvants to survival in Pagetic osteosarcoma, Clin Orthop Relat Res, 468, 2962, 10.1007/s11999-010-1473-7 · DOI
  51. Rendina, 2015, Clinical characteristics and evolution of giant cell tumor occurring in Paget's disease of bone, J Bone Miner Res, 30, 257, 10.1002/jbmr.2349 · DOI
  52. Divisato, 2016, ZNF687 mutations in severe Paget disease of bone associated with giant cell tumor, Am J Hum Genet, 98, 275, 10.1016/j.ajhg.2015.12.016 · DOI
  53. Selby, 2002, Guidelines on the management of Paget's disease of bone, Bone, 31, 366, 10.1016/S8756-3282(02)00817-7 · DOI · Paper page
  54. Takata, 2006, Guidelines for diagnosis and management of Paget's disease of bone in Japan, J Bone Miner Metab, 24, 359, 10.1007/s00774-006-0696-x · DOI
  55. Singer, 2014, Paget's disease of bone: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 99, 4408, 10.1210/jc.2014-2910 · DOI · Paper page
  56. Ralston, 2013, Clinical practice, Paget's disease of bone. N Engl J Med, 368, 644
  57. Hsu, 2011, Application of GRADE: making evidence-based recommendations about diagnostic tests in clinical practice guidelines, Implement Sci, 6, 62, 10.1186/1748-5908-6-62 · DOI
  58. Corral-Gudino, 2017, Bisphosphonates for Paget's disease of bone in adults, Cochrane Database Syst Rev, 12, CD004956
  59. Brouwers, 2016, The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines, BMJ, 352, i1152, 10.1136/bmj.i1152 · DOI · Paper page
  60. Eekhoff, 2004, Paget's disease of bone in The Netherlands: a population-based radiological and biochemical survey—the Rotterdam Study, J Bone Miner Res, 19, 566, 10.1359/jbmr.2004.19.4.566 · DOI
  61. Mirra, 1995, Paget's disease of bone: review with emphasis on radiologic features, Part II. Skeletal Radiol, 24, 173
  62. Guanabens, 2012, Implications of a new radiological approach for the assessment of Paget disease, Calcif Tissue Int, 91, 409, 10.1007/s00223-012-9652-z · doi:10.1007/s00223-012-9652-z
  63. Shirazi, 1974, Bone scanning in evaluation of Paget's disease of bone, CRC Crit Rev Clin Radiol Nucl Med, 5, 523
  64. Kim, 1997, The ‘mouse face’ appearance of the vertebrae in Paget's disease, Clin Nucl Med, 22, 104, 10.1097/00003072-199702000-00007 · doi:10.1097/00003072-199702000-00007
  65. Rotes-Sala, 2004, The clover and heart signs in vertebral scintigraphic images are highly specific of Paget's disease of bone, Bone, 34, 605, 10.1016/j.bone.2003.10.014 · doi:10.1016/j.bone.2003.10.014
  66. Reyes, 2008, Vertebral “clover” scintigraphic image in a vertebral metastasis misdiagnosed with Paget's disease, Clin Rheumatol, 27, 1585, 10.1007/s10067-008-1001-2 · doi:10.1007/s10067-008-1001-2
  67. Wellman, 1977, Skeletal scintimaging and radiography in the diagnosis and management of Paget's disease, Clin Orthop Relat Res, 127, 55
  68. Meunier, 1987, Skeletal distribution and biochemical parameters of Paget's disease, Clin Orthop Relat Res, 217, 37, 10.1097/00003086-198704000-00006 · DOI
  69. Fogelman, 1980, A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget's disease, Eur J Nucl Med, 5, 417, 10.1007/BF00261784 · doi:10.1007/bf00261784
  70. Roberts, 1989, Paget disease: MR imaging findings, Radiology, 173, 341, 10.1148/radiology.173.2.2798865 · doi:10.1148/radiology.173.2.2798865
  71. Tehranzadeh, 1998, Computed tomography of Paget disease of the skull versus fibrous dysplasia, Skeletal Radiol, 27, 664, 10.1007/s002560050456 · doi:10.1007/s002560050456
  72. Alvarez, 1997, Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity, Arthritis Rheum, 40, 461, 10.1002/art.1780400312 · DOI
  73. Alvarez, 1995, Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease, J Bone Miner Res, 10, 458, 10.1002/jbmr.5650100318 · doi:10.1002/jbmr.5650100318
  74. Woitge, 1999, Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices, J Bone Miner Res, 14, 792, 10.1359/jbmr.1999.14.5.792 · DOI · Paper page
  75. Al Nofal, 2015, Bone turnover markers in Paget's disease of the bone: a systematic review and meta-analysis, Osteoporos Int, 26, 1875, 10.1007/s00198-015-3095-0 · DOI
  76. Langston, 2007, Clinical determinants of quality of life in Paget's disease of bone, Calcif Tissue Int, 80, 1, 10.1007/s00223-006-0184-2 · DOI
  77. Condon, 1971, Glucagon in the treatment of Paget's disease of bone, Br Med J, 4, 719, 10.1136/bmj.4.5789.719 · doi:10.1136/bmj.4.5789.719
  78. Heath, 1981, The role of mithramycin in the management of Paget's disease, Metab Bone Dis Relat Res, 3, 343, 10.1016/0221-8747(81)90051-5 · doi:10.1016/0221-8747(81)90051-5
  79. Fennelly, 1971, Effect of actinomycin D on Paget's disease of bone, Br Med J, 1, 423, 10.1136/bmj.1.5746.423 · doi:10.1136/bmj.1.5746.423
  80. Bockman, 1995, A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone, J Clin Endocrinol Metab, 80, 595
  81. Reid, 2016, Treatment of Paget's disease of bone with denosumab: case report and literature review, Calcif Tissue Int, 99, 322, 10.1007/s00223-016-0150-6 · DOI
  82. Kanis, 1975, Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses, Q J Med, 44, 399
  83. Ralston, 1987, The effect of one alpha hydroxyvitamin D3 on the mineralisation defect in disodium etidronate treated Paget's disease—a double-blind randomized study, J Bone Miner Res, 2, 5, 10.1002/jbmr.5650020103 · DOI
  84. Altman, 1973, Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans), N Engl J Med, 289, 1379, 10.1056/NEJM197312272892601 · DOI · Paper page
  85. Canfield, 1977, Diphosphonate therapy of Paget's disease of bone, J Clin Endocrinol Metab, 44, 96, 10.1210/jcem-44-1-96 · DOI · Paper page
  86. Fraser, 1997, A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone, Postgrad Med J, 73, 496, 10.1136/pgmj.73.862.496 · DOI
  87. McClung, 1995, Tiludronate therapy for Paget's disease of bone [published erratum appears in Bone 1996 Mar;18(3):292], Bone, 17, 493S, 10.1016/8756-3282(95)00282-1 · doi:10.1016/8756-3282(95)00282-1
  88. Reginster, 1992, Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study, Arthritis Rheumatism, 35, 967, 10.1002/art.1780350819 · doi:10.1002/art.1780350819
  89. Merlotti, 2007, Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone, J Bone Miner Res, 22, 1510, 10.1359/jbmr.070704 · DOI
  90. Walsh, 2004, A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone, Bone, 34, 747, 10.1016/j.bone.2003.12.011 · doi:10.1016/j.bone.2003.12.011
  91. Reid, 2005, Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease, N Engl J Med, 353, 898, 10.1056/NEJMoa044241 · DOI · Paper page
  92. Reid, 2011, A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years, J Bone Miner Res, 26, 2261, 10.1002/jbmr.438 · DOI
  93. Monsell, 1995, Hearing loss in Paget's disease of bone: evidence of auditory nerve integrity, Am J Otol, 16, 27
  94. Donath, 2004, Effect of bisphosphonate treatment in patients with Paget's disease of the skull, Rheumatology (Oxford), 43, 89, 10.1093/rheumatology/keg477 · DOI
  95. Wegrzyn, 2010, Cementless total hip arthroplasty in Paget's disease of bone: a retrospective review, Int Orthop, 34, 1103, 10.1007/s00264-009-0853-7 · doi:10.1007/s00264-009-0853-7
  96. Gabel, 1991, Total knee arthroplasty for osteoarthrosis in patients who have Paget disease of bone at the knee, J Bone Joint Surg Am, 73, 739, 10.2106/00004623-199173050-00013 · doi:10.2106/00004623-199173050-00013
  97. Lee, 2005, Total knee arthroplasty in patients with Paget's disease of bone at the knee, J Arthroplasty, 20, 689, 10.1016/j.arth.2004.11.007 · doi:10.1016/j.arth.2004.11.007
  98. Jorge-Mora, 2016, Surgical treatment in spine Paget's disease: a systematic review, Eur J Orthop Surg Traumatol, 26, 27, 10.1007/s00590-015-1659-5 · doi:10.1007/s00590-015-1659-5
  99. Parvizi, 2003, Corrective osteotomy for deformity in Paget disease, J Bone Joint Surg Am, 85-A, 697, 10.2106/00004623-200304000-00017 · doi:10.2106/00004623-200304000-00017
  100. Bickerstaff, 1990, Improvement in the deformity of the face in Paget's disease treated with diphosphonates, J Bone Joint Surg Br, 72, 132, 10.1302/0301-620X.72B1.2137127 · doi:10.1302/0301-620x.72b1.2137127
  101. Chen, 1979, Neurologic disturbances in Paget disease of bone: response to calcitonin, Neurology, 29, 448, 10.1212/WNL.29.4.448 · doi:10.1212/wnl.29.4.448
  102. Miller, 1999, A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group, Am J Med, 106, 513, 10.1016/S0002-9343(99)00062-5 · DOI · Paper page
  103. Gutteridge, 1996, Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study, Bone, 19, 387, 10.1016/S8756-3282(96)00224-4 · doi:10.1016/s8756-3282(96)00224-4
  104. Siris, 1996, Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone, J Clin Endocrinol Metab, 81, 961
  105. Tan, 2017, Long-term randomized trial of intensive versus symptomatic management in Paget's disease of bone: the PRISM-EZ Study, J Bone Miner Res, 32, 1165, 10.1002/jbmr.3066 · DOI
  106. Reid, 2010, Characterization of and risk factors for the acute-phase response after zoledronic acid, J Clin Endocrinol Metab, 95, 4380, 10.1210/jc.2010-0597 · DOI · Paper page
  107. Merlotti, 2011, Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone, J Bone Miner Res, 26, 512, 10.1002/jbmr.237 · DOI
  108. Martin, 1977, Clinical, biochemical and histological observations on the effect of porcine calcitonin in Paget's disease of bone, Aust N Z J Med, 7, 36, 10.1111/j.1445-5994.1977.tb03354.x · DOI
  109. O'Donoghue, 1987, Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease, Bone, 8, 219, 10.1016/8756-3282(87)90168-2 · doi:10.1016/8756-3282(87)90168-2
  110. Schwarz, 2012, Paget's disease of the bone after treatment with Denosumab: a case report, Bone, 50, 1023, 10.1016/j.bone.2012.01.020 · DOI
  111. Ueda, 2015, Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial, Ann Oncol, 26, 2149, 10.1093/annonc/mdv307 · doi:10.1093/annonc/mdv307
  112. Chawla, 2013, Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study, Lancet Oncol, 14, 901, 10.1016/S1470-2045(13)70277-8 · DOI · Paper page
  113. Thomas, 2010, Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study, Lancet Oncol, 11, 275, 10.1016/S1470-2045(10)70010-3 · DOI · Paper page
  114. Cosso, 2010, Giant cell tumor in a case of Paget's disease of bone: an aggressive benign tumor exhibiting a quick response to an innovative therapeutic agent, Clin Cases Miner Bone Metab, 7, 145
  115. Verma, 2016, giant cell tumor developing in Paget's disease of bone: a case report with review of literature, J Orthop Case Rep, 6, 103
  116. Tanaka, 2017, Anti-osteoclastic agent, denosumab, for a giant cell tumor of the bone with concurrent Paget's disease: a case report, Oncol Lett, 13, 2105, 10.3892/ol.2017.5693 · doi:10.3892/ol.2017.5693
  117. Boudreau, 1983, Observations on serial radionuclide blood-flow studies in Paget's disease: concise communication, J Nucl Med, 24, 880
  118. Nicholas, 1965, Fracture of the femur in patients with Paget's disease; results of treatment in twenty-three cases, J Bone Joint Surg Am, 47, 450, 10.2106/00004623-196547030-00002 · doi:10.2106/00004623-196547030-00002
  119. Verinder, 1979, The management of fractures in Paget's disease of bone, Injury, 10, 276, 10.1016/0020-1383(79)90043-3 · doi:10.1016/0020-1383(79)90043-3
  120. Grundy, 1970, Fractures of the femur in Paget's disease of bone. Their etiology and treatment, J Bone Joint Surg Br, 52, 252, 10.1302/0301-620X.52B2.252 · doi:10.1302/0301-620x.52b2.252
  121. Bradley, 1992, Outcome after fractures of the femur in Paget's disease, Aust N Z J Surg, 62, 39, 10.1111/j.1445-2197.1992.tb05352.x · doi:10.1111/j.1445-2197.1992.tb05352.x
  122. Bidner, 1989, Femoral fractures in Paget's disease, J Orthop Trauma, 3, 317, 10.1097/00005131-198912000-00011 · doi:10.1097/00005131-198912000-00011
  123. McDonald, 1987, Total hip arthroplasty in Paget's disease, A follow-up note. J Bone Joint Surg Am, 69, 766, 10.2106/00004623-198769050-00020 · doi:10.2106/00004623-198769050-00020
  124. Parvizi, 2002, Outcome of uncemented hip arthroplasty components in patients with Paget's disease, Clin Orthop Relat Res, 403, 127, 10.1097/00003086-200210000-00020 · doi:10.1097/00003086-200210000-00020
  125. Roper, 1971, Paget's disease at the hip with osteoarthrosis: results of intertrochanteric osteotomy, J Bone Joint Surg Br, 53, 660, 10.1302/0301-620X.53B4.660 · doi:10.1302/0301-620x.53b4.660

Cited by

See all 225

Metadata

Authors
Ralston, S. H., Corral-Gudino, L., Cooper, C., Francis, R. M., Fraser, W. D., Gennari, L., Guañabens, N., Javaid, M. K., Layfield, R., O'Neill, T. W., Russell, R. G. G., Stone, M. D., Simpson, K., Wilkinson, D., Wills, R., Zillikens, M. C., & Tuck, S. P.
Venue
Journal of Bone and Mineral Research
Published
2019-02-25
Volume
34
Issue
4
Pages
579-604
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2907719236
Cited by
225
References
8
FWCI
7.98
Type
journal article
Language
en
Open access
hybrid
Funders
International Osteoporosis Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline. https://app.cochat.ai/papers/10.1002/jbmr.3657
The paper
Ralston, S. H., Corral-Gudino, L., Cooper, C., Francis, R. M., Fraser, W. D., Gennari, L., Guañabens, N., Javaid, M. K., Layfield, R., O'Neill, T. W., Russell, R. G. G., Stone, M. D., Simpson, K., Wilkinson, D., Wills, R., Zillikens, M. C., & Tuck, S. P. (2019). Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.3657

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.